EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of progressive gastric cancer, colorectal cancer, pancreatic cancer, breast cancer, as well as tumors in the head and neck area.
Dosage form: concentrate for infusion solution
Active substance Dosage fluorouracil 50 mg/ml ATC: L01BC02
-
The drug is intended for adult patients for the treatment of progressive epithelial ovarian cancer (as both first-line and second-line therapy) and small cell lung cancer.
Dosage form: concentrate for infusion solution
Active substance Dosage carboplatin 10 mg/ml ATC: L01XA02
-
The drug is prescribed for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.
Dosage form: concentrate for infusion solution
Active substance Dosage docetaxel 10 mg/ml ATC: L01CD02
-
The drug is used to treat a wide range of neoplastic diseases, including acute leukemia, lymphoma, solid tumors in adults (e.g., breast and lung cancer), as well as malignant neoplasms in children.
Dosage form: concentrate for infusion solution
Active substance Dosage doxorubicin 2 mg/ml ATC: L01DB01
-
The drug is used to treat a wide range of neoplasms, including breast, stomach, liver, pancreatic, lung, ovarian, and rectal cancer, as well as malignant lymphomas, soft tissue sarcomas, leukemia, and superficial bladder cancer.
Dosage form: concentrate for infusion solution
Active substance Dosage epirubicin 2 mg/ml ATC: L01DB03
-
The drug is used for the treatment of bile duct cancer, bladder cancer, breast cancer, non-small cell lung cancer, ovarian cancer, and pancreatic cancer.
Dosage form: concentrate for infusion solution
Active substance Dosage gemcitabine 40 mg/ml ATC: L01BC05
-
It is used for antirheumatic therapy (e.g., for rheumatoid arthritis), for the treatment of severe forms of psoriasis, and as a cytostatic agent in acute leukemia.
Dosage form: tablets
Active substance Dosage methotrexate 2.5 mg -
It is used for antirheumatic therapy (for example, in rheumatoid arthritis), for the treatment of severe forms of psoriasis, and as a cytostatic agent during maintenance therapy for acute leukemia.
Dosage form: tablets
Active substance Dosage methotrexate 5 mg -
The drug is used for anti-rheumatic therapy (e.g., for rheumatoid arthritis), for the treatment of severe forms of psoriasis, and as a cytostatic agent in maintenance therapy for acute leukemia.
Dosage form: tablets
Active substance Dosage methotrexate 10 mg -
The drug is used to treat rheumatoid arthritis, psoriasis (particularly the plaque type), psoriatic arthritis, as well as for the therapy of certain types of cancer (e.g., breast cancer, non-Hodgkin lymphoma, acute lymphoblastic leukemia, and malignant trophoblastic tumors).
Dosage form: solution for injection
Active substance Dosage methotrexate 10 mg/ml ATC: L01BA01
-
The drug is used to treat adults and children from 3 years of age for various oncological diseases, including malignant tumors, breast cancer, head and neck cancer, non-Hodgkin lymphoma, and acute lymphoblastic leukemia. It is also used for the prevention and treatment of carcinomatous meningitis.
Dosage form: concentrate for infusion solution
Active substance Dosage methotrexate 100 mg/ml ATC: L01BA01
-
The drug is used in combination with 5-fluorouracil and folinic acid for adjuvant therapy of stage III colorectal cancer (after tumor removal) and for the treatment of metastatic colorectal cancer.
Dosage form: concentrate for infusion solution
Active substance Dosage oxaliplatin 5 mg/ml ATC: L01XA03
-
The drug is used for the chemotherapy of ovarian cancer, breast cancer, advanced non-small cell lung cancer, as well as for the treatment of Kaposi's sarcoma in patients with AIDS.
Dosage form: concentrate for infusion solution
Active substance Dosage paclitaxel 6 mg/ml ATC: L01CD01
-
The drug is used for the treatment of non-small cell lung cancer (stages 3–4), as well as for the treatment of metastatic breast cancer (stage 4) in cases where other methods of therapy have failed or are not possible.
Dosage form: concentrate for infusion solution
Active substance Dosage vinorelbine 10 mg/ml ATC: L01CA04